{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:33:52Z","timestamp":1770831232121,"version":"3.50.1"},"reference-count":12,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"OBJECTIVE<\/jats:title>Methylprednisolone sodium succinate (MPSS) has been studied as a pharmacological adjunct that may be given to patients with acute spinal cord injury (ASCI) to improve neurological recovery. MPSS treatment became the standard of care in adults despite a lack of evidence supporting clinical benefit. More recently, new guidelines from neurological surgeon groups recommended no longer using MPSS for ASCI, due to questionable clinical benefit and known complications. However, little information exists in the pediatric population regarding MPSS use in the setting of ASCI. The aim of this paper was to describe steroid use and side effects in patients with ASCI at the authors\u2019 Level 1 pediatric trauma center in order to inform other hospitals that may still use this therapy.<\/jats:p><\/jats:sec>METHODS<\/jats:title>A retrospective chart review was conducted to determine adherence in ordering and delivery according to the guideline of the authors\u2019 institution and to determine types and frequency of complications. Inclusion criteria included age < 17 years, blunt trauma, physician concern for ASCI, and admission for \u2265 24 hours or treatment with high-dose intravenous MPSS. Exclusion criteria included penetrating trauma, no documentation of ASCI, and incomplete medical records. Charts were reviewed for a predetermined list of complications.<\/jats:p><\/jats:sec>RESULTS<\/jats:title>A total of 602 patient charts were reviewed; 354 patients were included in the study. MPSS was administered in 59 cases. In 34 (57.5%) the order was placed correctly. In 13 (38.2%) of these 34 cases, MPSS was administered according to the recommended timeline protocol. Overall, only 13 (22%) of 59 patients received the therapy according to protocol with regard to accurate ordering and administration.<\/jats:p>Among the patients with ASCI, 20 (55.6%) of the 36 who received steroids had complications, which was a significantly higher rate than in those who did not receive steroids (8 [24.2%] of 33, p = 0.008). Among the patients without ASCI, 10 (43.5%) of the 23 who received steroids also experienced significantly more complications than patients who did not receive steroids (50 [19.1%] of 262, p = 0.006).<\/jats:p><\/jats:sec>CONCLUSIONS<\/jats:title>High-dose MPSS for ASCI was not delivered to pediatric patients according to protocol with a high degree of reliability. Patients receiving steroids for pediatric ASCI were significantly more likely to experience complications than patients not receiving steroids. The findings presented, including complications of steroid use, support removal of high-dose MPSS as a treatment option for pediatric ASCI.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2017.7.peds1756","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T13:57:20Z","timestamp":1507298240000},"page":"567-574","source":"Crossref","is-referenced-by-count":25,"title":["Lessons learned from administration of high-dose methylprednisolone sodium succinate for acute pediatric spinal cord injuries"],"prefix":"10.3171","volume":"20","author":[{"given":"Michelle C.","family":"Caruso","sequence":"first","affiliation":[{"name":"Divisions of Pharmacy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot C.","family":"Daugherty","sequence":"additional","affiliation":[{"name":"Trauma Services,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Moody","sequence":"additional","affiliation":[{"name":"Trauma Services,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Falcone","sequence":"additional","affiliation":[{"name":"Trauma Services,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin S.","family":"Bierbrauer","sequence":"additional","affiliation":[{"name":"Neurosurgery, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Geis","sequence":"additional","affiliation":[{"name":"Emergency Medicine and Center for Simulation and Research, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"Suppl 3","key":"b1","series-title":"Neurosurgery","first-page":"S63","article-title":"Pharmacological therapy after acute cervical spinal cord injury","volume":"50","year":"2002","unstructured":"American Association of Neurological Surgeons\/Congress of Neurological Surgeons Joint Section on Disorders of the Spine and Peripheral Nerves: Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 50 (Suppl 3):S63\u2013S72, 2002"},{"key":"b2","series-title":"J Pediatr Orthop","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/BPO.0000000000000364","article-title":"Complications associated with high-dose corticosteroid administration in children with spinal cord injury","volume":"35","author":"Cage JM","year":"2015","unstructured":"Cage JM, Knox JB, Wimberly RL, Shaha S, Jo C, Riccio AI: Complications associated with high-dose corticosteroid administration in children with spinal cord injury. J Pediatr Orthop 35:687\u2013692, 20152549403110.1097\/BPO.0000000000000364"},{"key":"b3","series-title":"Crit Care","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/cc10578","article-title":"Protocols in the management of critical illness","volume":"16","author":"Chang SY","year":"2012","unstructured":"Chang SY, Sevransky J, Martin GS: Protocols in the management of critical illness. Crit Care 16:306, 20122242413010.1186\/cc10578"},{"issue":"1 Suppl","key":"b4","series-title":"J Neurosurg","first-page":"1","article-title":"Methylprednisolone for acute spinal cord injury: an inappropriate standard of care","volume":"93","author":"Hurlbert RJ","year":"2000","unstructured":"Hurlbert RJ: Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93 (1 Suppl):1\u20137, 200010879751"},{"issue":"Suppl 2","key":"b5","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1227\/NEU.0b013e31827765c6","article-title":"Pharmacological therapy for acute spinal cord injury","volume":"72","author":"Hurlbert RJ","year":"2013","unstructured":"Hurlbert RJ, Hadley MN, Walters BC, Aarabi B, Dhall SS, Gelb DE, : Pharmacological therapy for acute spinal cord injury. Neurosurgery 72 (Suppl 2):93\u2013105, 20132341718210.1227\/NEU.0b013e31827765c6"},{"issue":"Suppl 1","key":"b6","series-title":"Surgical Neurosurg","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.surneu.2007.06.085","article-title":"Pitfalls in the treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients","volume":"68","author":"Lee HC","year":"2007","unstructured":"Lee HC, Cho DY, Lee WY, Chuang HC: Pitfalls in the treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients. Surgical Neurosurg 68 Suppl 1:S37\u2013S42, 200710.1016\/j.surneu.2007.06.085"},{"key":"b7","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/00007632-200102150-00020","article-title":"Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury","volume":"26","author":"Matsumoto T","year":"2001","unstructured":"Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H: Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976) 26:426\u2013430, 20011122489110.1097\/00007632-200102150-00020"},{"key":"b8","series-title":"J Trauma","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/00005373-199812000-00021","article-title":"Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials","volume":"45","author":"Nesathurai S","year":"1998","unstructured":"Nesathurai S: Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 45:1088\u20131093, 199810.1097\/00005373-199812000-000219867054"},{"key":"b9","series-title":"Pediatr Surg Int","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00383-011-3012-3","article-title":"A review: the role of high dose methylprednisolone in spinal cord trauma in children","volume":"28","author":"Pettiford JN","year":"2012","unstructured":"Pettiford JN, Bikhchandani J, Ostlie DJ, St Peter SD, Sharp RJ, Juang D: A review: the role of high dose methylprednisolone in spinal cord trauma in children. Pediatr Surg Int 28:287\u2013294, 20122199407910.1007\/s00383-011-3012-3"},{"key":"b10","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.spinee.2005.11.001","article-title":"Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature","volume":"6","author":"Sayer FT","year":"2006","unstructured":"Sayer FT, Kronvall E, Nilsson OG: Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 6:335\u2013343, 20061665123110.1016\/j.spinee.2005.11.001"},{"key":"b11","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.sc.3100986","article-title":"High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective","volume":"38","author":"Short DJ","year":"2000","unstructured":"Short DJ, El Masry WS, Jones PW: High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective. Spinal Cord 38:273\u2013286, 200010.1038\/sj.sc.310098610822400"},{"key":"b12","series-title":"Injury","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.injury.2007.12.005","article-title":"Early complications of high-dose methylprednisolone in acute spinal cord injury patients","volume":"39","author":"Suberviola B","year":"2008","unstructured":"Suberviola B, Gonzalex-Castro A, Llorca J, Ortiz-Melon F, Minambres E: Early complications of high-dose methylprednisolone in acute spinal cord injury patients. Injury 39:748\u2013752, 20081854124110.1016\/j.injury.2007.12.005"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/20\/6\/article-p567.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/20\/6\/article-p567.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/20\/6\/article-p567.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T13:56:03Z","timestamp":1681566963000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/20\/6\/article-p567.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":12,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2017.7.peds1756","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}